In Vitro Evaluation of Repurposed Antivirals and Their Combinations Against Respiratory Syncytial Virus and Human Parainfluenza Virus Type 2: Evidence of Ribavirin–Oseltamivir Synergy
Fatima Nur Olcay, Tuba Sevimoglu, Sibel Dosler. In Vitro Evaluation of Repurposed Antivirals and Their Combinations Against Respiratory Syncytial Virus and Human Parainfluenza Virus Type 2: Evidence of Ribavirin–Oseltamivir Synergy. // Journal of Medical Virology. – 2026. – DOI: 10.1002/jmv.71202. – URL: https://onlinelibrary.wiley.com/doi/10.1002/jmv.71202?af=R
Fatima Nur Olcay, Tuba Sevimoglu, & Sibel Dosler (2026). In Vitro Evaluation of Repurposed Antivirals and Their Combinations Against Respiratory Syncytial Virus and Human Parainfluenza Virus Type 2: Evidence of Ribavirin–Oseltamivir Synergy. Journal of Medical Virology. https://doi.org/10.1002/jmv.71202
Fatima Nur Olcay, et al. “In Vitro Evaluation of Repurposed Antivirals and Their Combinations Against Respiratory Syncytial Virus and Human Parainfluenza Virus Type 2: Evidence of Ribavirin–Oseltamivir Synergy.” Journal of Medical Virology, 2026. doi:10.1002/jmv.71202.
@article{Olcay2026,
title = {In Vitro Evaluation of Repurposed Antivirals and Their Combinations Against Respiratory Syncytial Virus and Human Parainfluenza Virus Type 2: Evidence of Ribavirin–Oseltamivir Synergy},
author = {Olcay, Fatima Nur and Sevimoglu, Tuba and Dosler, Sibel},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71202},
url = {https://onlinelibrary.wiley.com/doi/10.1002/jmv.71202?af=R}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...